Search

everythinglearnresearchcommunity

for

Search:↓

Topical vitamin D3 does not prevent hair loss from chemotherapy.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The formula YH0618 can reduce the harmful side effects of the chemotherapy drug Doxorubicin and protect healthy cells.

Pressure-induced hair loss is rare, often reversible, and early diagnosis is crucial to prevent complications.

Ginseng, especially its component ginsenosides, can promote hair growth, reduce hair loss, and potentially treat conditions like alopecia by affecting cell pathways and cytokines.

Cedrol may prevent hair loss caused by chemotherapy better than minoxidil.

New treatments for hair loss are being developed using molecular biology.

Ganoderma lucidum extract promotes hair growth in bald rats, with higher doses producing better results, similar to the effects of Minoxidil 2%.

New treatments for hair loss show promise, including plasma, stem cells, and hair-stimulating complexes, but more research is needed to fully understand them.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Chemotherapy damages hair follicles, causing hair loss and other cellular changes.

Scalp cooling is largely ineffective in preventing hair loss from breast cancer chemotherapy.

New regenerative treatments for hair loss show promise but need more research for confirmation.

The YH complex, made from Astragalus membranaceus and Cinnamomum cassia, may help treat hair loss by promoting hair growth and follicle development.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

Retinoic acid helps change skin cells and is important for skin development and hair growth.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Some drugs can cause hair loss, and stopping these drugs often leads to hair regrowth.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

People with hair loss have low zinc levels; zinc supplements and laser therapy may help.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Prostaglandin F2α analogs show promise for treating certain types of hair loss but need more research for other skin conditions.

High-dose radiation speeds up aging in skin stem cells.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Recent advances in hair loss treatments show significant progress.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Higher DKK-1 levels found in hair loss patients; L-ascorbic acid 2-phosphate, L-threonate, and ginsenoside F2 may help promote hair growth.